Liquidity is critically constrained, as evidenced by a $265.9K negative free cash flow in 2026Q2 and a cash balance that has dwindled to just $4.6K.
| Cash from Operations | -1.52M | -1.32M | -820.96K | -207 | -128 |
| Operating CF Margin % | - | - | - | - | - |
| Operating CF Growth % | -284.65% | -60.56% | -396498.55% | -61.72% | - |
| Net Income | 986.21K | 3.42M | 1.87M | -6.84K | -578 |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.8M | -5.13M | -3.03M | 0 | 0 |
| Working Capital Changes | 298.12K | 396.44K | 338.53K | 6.64K | 450 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -45.2K | -12.96K | 78.73K | 0 | 0 |
| Cash from Investing | 114.91M | 107.84M | -115.58M | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - |
| Acquisitions | 0 | - | - | - | - |
| Investments | 0 | 15.89M | 118.6M | 0 | 0 |
| Other Investing | 892.37K | 107.84M | -115.58M | 0 | 0 |
| Cash from Financing | -114.02M | -106.13M | 117.17M | 50K | 0 |
| Debt Issued (Net) | 0 | - | - | - | - |
| Equity Issued (Net) | -114.02M | -106.13M | 117.66M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -114.02M | -106.13M | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -488.8K | 50K | 0 |
| Net Change in Cash | -622.74K | 393.27K | 770.25K | 49.79K | -128 |
| Free Cash Flow | -1.52M | -1.32M | -820.96K | -207 | -128 |
| FCF Margin % | - | - | - | - | - |
| FCF Growth % | -23.47% | -60.56% | -396498.55% | -61.72% | - |
| FCF per Share | -1.05 | -0.12 | -0.05 | -0.00 | -0.00 |
| FCF Conversion (FCF/Net Income) | -1.54x | -0.39x | -0.44x | 0.03x | 0.22x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Liquidation and deal failure
As reported in financial statements, IBAC exhibits a persistent disconnect between net income and operating cash flow, with the OCF/NI ratio fluctuating wildly, including a 17.84x reading in 2026Q1, which underscores the lack of meaningful operational cash generation inherent in a pre-revenue shell company structure.
The extreme volatility in the conversion ratio suggests that net income is driven by non-cash accounting adjustments rather than core business activities. Investors should monitor this divergence as it confirms that reported earnings provide no reliable signal regarding the company's actual ability to fund its ongoing search for a target.
Based on the provided financial data, IBAC has consistently reported negative free cash flow across all ten quarters, with a notable cash outflow of $265.9K in 2026Q2, indicating that the entity is actively consuming its limited capital reserves to sustain its administrative and due diligence operations.
The persistent negative FCF trajectory suggests that the company is burning through its available liquidity without any offsetting revenue streams. This trend warrants further investigation into how much longer the current cash balance can support the search process before the entity faces a liquidity crisis.
According to recent SEC filings, IBAC's working capital changes have been highly erratic, swinging from a $511.1K inflow in 2026Q2 to an $838.4K outflow in 2026Q1, which suggests that management is attempting to manage cash timing to offset the ongoing operational burn rate.
These fluctuations in working capital appear to be a defensive mechanism to preserve cash, yet they fail to mask the underlying trend of capital depletion. The reliance on these shifts suggests that the company lacks a stable cash management strategy, increasing the risk of a forced liquidation if a deal is not reached.
As indicated by the historical data, IBAC utilized $106.1M for share repurchases in 2025Q4, a significant deployment that appears disconnected from its pre-revenue status and limited cash reserves, potentially signaling an aggressive attempt to manage equity value at the expense of long-term operational liquidity.
The substantial capital outflow for buybacks in 2025Q4 raises questions regarding the sponsor's capital allocation priorities. Investors should monitor whether such deployments have permanently impaired the company's ability to fund the necessary due diligence required to secure a viable business combination.
Quick answers to the most common questions about buying IBAC stock.
IB Acquisition Corp. Common Stock (IBAC) generated $-1.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
IB Acquisition Corp. Common Stock (IBAC) reported negative free cash flow of $1.3M in 2025, indicating capital requirements exceeded cash from operations.
IB Acquisition Corp. Common Stock (IBAC) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, IB Acquisition Corp. Common Stock (IBAC) spent $106.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.